1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Melexis N.V.
  6. News
  7. Summary
    MELE   BE0165385973

MELEXIS N.V.

(MELE)
  Report
Real-time Euronext Bruxelles  -  11:36 2022-08-08 am EDT
82.20 EUR   -0.72%
07/27Melexis NV Announces Interim Dividend, Payable on October 18, 2022
CI
07/27TRANSCRIPT : Melexis NV, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27Melexis NV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Melexis N : Proxy to the ordinary shareholders' meeting 2022

04/08/2022 | 03:59am EDT

[ONLY FOR TRANSLATION PURPOSES,

THE FILLED OUT AND SIGNED PROXY NEEDS TO BE IN DUTCH]

PROXY1

The undersigned:

(full name and address of the shareholder)

Owner - joint owner - bare owner - usufructuary - pledgor - pledgee - custodian2 (delete as appropriate)

of ______________________ registered shares - dematerialized shares (delete as appropriate)

of MELEXIS NV, with registered office at Rozendaalstraat 12, 8900 Ieper, listed in the register of legal persons of Ieper with company number 0435.604.729.

Herewith appoints as special proxy holder:

(name, place of birth, date of birth and address)

To whom he/she grants proxy to:

Participate on his/her behalf to the annual shareholders' meeting that will be held on May 10th, 2022 at 11h00 at Melexis Technologies NV, Transportstraat 1, 3980 Tessenderlo, Belgium:

ANNUAL SHAREHOLDERS' MEETING AGENDA

  • 1. Acknowledgement and explanation of the annual report of the board of directors regarding the statutory annual accounts for the financial year ended on December 31st, 2021, with explanation of the remuneration report that is included in the corporate governance statement.

    Explanatory statement: Pursuant to Articles 3:5 and 3:6 of the Belgian Code on Companies and Associations (the "BCCA"), the directors have drafted an annual report in which they account for their management. This agenda item does not require a resolution of the shareholders.

  • 2. Acknowledgement and explanation of the statutory auditor's report regarding the statutory annual

  • accounts for the financial year ended on December 31st, 2021.

1 This proxy is not a proxy solicitation and cannot be used in the cases contemplated by articles 7:144 and 7:145 of the Belgian Code on companies and associations.

2 In accordance with articles 9 and 29 of the articles of association the joint owners, the pledgers and pledges, the bare owners and usufructuaries of shares and custodians are requested to appoint one single proxy holder.

Explanatory statement: Pursuant to Articles 3:74 and 3:75 of the BCCA, the statutory auditor has drafted a detailed report. This agenda item does not require a resolution of the shareholders.

  • 3. Acknowledgement and explanation of the consolidated annual accounts, the report of the board of directors and the statutory auditor's report with regard to the consolidated annual accounts for the financial year ended on December 31st, 2021.

    Explanatory statement: The board of directors submits the consolidated annual accounts for discussion. Pursuant to Article 3:32 of the BCCA, the directors have drafted a report on the consolidated annual accounts. Pursuant to Article 3:80 of the BCCA, the statutory auditor has drafted a detailed report on the consolidated annual accounts. This agenda item does not require a resolution of the shareholders.

  • 4. Approval of the statutory annual accounts and other documents to be deposited in accordance with the BCCA for the financial year ended on December 31st, 2021, with allocation of the financial result.

    Proposed resolution: Subsequent to the acknowledgement and discussion of the reports of the board of directors and the statutory auditor and to the discussion of the statutory annual accounts and other documents to be deposited in accordance with the BCCA, and the consolidated annual accounts for the financial year ended on December 31st, 2021, the statutory annual accounts for the financial year ended on December 31st, 2021, are approved.

    The ordinary result amounts to EUR 3,774,141. Including the result carried forward from the financial year ended on December 31st, 2020, the total result to be appropriated for the financial year ended on December 31st, 2021, amounts to EUR 831,979,238. The shareholders' meeting approves that this result be allocated as determined in the annual accounts closed on December 31st, 2021, as follows:

    - - -

    Withdrawals from reserves EUR (3,837,828) Result to be carried forward: EUR 730,777,066 Gross dividend: EUR 105,040,000 (*)

    (*) On a per share basis this represents a gross dividend for 2021 of EUR 2.60. On January 28th, 2022, the board of directors decided to propose to the annual shareholders' meeting to pay out over the result of 2021 a total dividend of 2.60 EUR gross per share. This amount contains an interim dividend of 1.30 EUR per share which was paid in October 2021 and a final dividend of 1.30 EUR per share which will be payable after approval of the annual shareholders' meeting. The Melexis shares will start trading ex coupon on May 11th, 2022 (opening of the market). The record date is May 12th, 2022 (closing of the market) and the dividend will be payable as from May 13th, 2022.

  • 5. Approval of the remuneration report regarding the financial year ended on December 31st, 2021.

    Proposed resolution: The shareholders' meeting approves the remuneration report regarding the financial year ended on December 31st, 2021.

  • 6. Discharge from liability to the directors.

    Proposed resolution: The directors and their permanent representatives are, by separate vote for each director, discharged from liability for their mandate executed during the financial year ended on December 31st, 2021.

  • 7. Discharge from liability to the statutory auditor.

    Proposed resolution: The statutory auditor is discharged from liability for its mandate executed during the financial year ended on December 31st, 2021.

  • 8. Re-appointment of director and determination of their remuneration.

    Proposed resolution: The meeting decides to proceed to the re-appointment of Ms. Françoise Chombar as director for a period of four years, with effect as from today and ending immediately after the annual shareholders' meeting that will decide on the annual accounts of the financial year ended on December 31st, 2025.

    The director waives any remuneration for this mandate.

  • 9. Re-appointment of director and determination of their remuneration.

    Proposed resolution: The meeting decides to proceed to the re-appointment of Mr. Roland Duchâtelet as director for a period of four years, with effect as from today and ending immediately after the annual shareholders' meeting that will decide on the annual accounts of the financial year ended on December 31st, 2025.

    The director waives any remuneration for this mandate.

  • 10. Re-appointment of independent director and determination of their remuneration.

    Proposed resolution: The meeting decides to proceed to the re-appointment of Ms. Martine Baelmans as independent director, in accordance with Article 7:87 of the BCCA and provision 4 of the Belgian Corporate Governance Code 2020, for a period of four years, with effect as from today and ending immediately after the annual shareholders' meeting that will decide on the annual accounts of the financial year ended on December 31st, 2025.

    The director will receive an annual gross remuneration of EUR 20,000.00 for this mandate.

11. Determination of the statutory auditor's remuneration.

Proposed resolution: The statutory auditor's fee of fiscal year 2021 amounts to EUR 88,735.00 (plus VAT, out-of-pocket expenses and the IRE/IBR fee) and is subject to annual adjustment based on the consumer price index or as agreed between the parties.

VOTING INSTRUCTIONS ANNUAL SHAREHOLDERS' MEETING

Complete your voting instructions here:

1.

Statutory annual report of the board of directors on the financial year 2021 (does not involve a vote)

2. Report of the statutory auditor regarding the statutory annual accounts on the financial year 2021

(does not involve a vote)

3.

Report on the consolidated annual accounts on the financial year 2021 (does not involve a vote)

4.

Approval statutory annual accounts for the financial year 2021 with allocation of the result

5.

6.

7.

abstain

abstain

abstain

Discharge liability statutory auditor

abstain

  • for

  • against

Approval remuneration report financial year 2021

  • for

  • against

Discharge liability directors

  • for

    • against

  • for

  • against

8.

Approval re-appointment of director and determination of their remuneration

  • for

  • against

  • abstain

9.

Approval re-appointment of director and determination of their remuneration

  • for

  • against

  • abstain

10. Approval re-appointment of independent director and determination of their remuneration

abstain

11. Approval statutory auditor's remuneration

abstain

  • for

    • against

  • for

  • against

Done at [location] on: [date]

Signature of the shareholder (preceded by the hand-written words "Good for proxy")

If the shareholder is not a natural person:

Name of the individual signatory:

Function:

who certifies being authorized to sign this proxy for and on behalf of the shareholder identified on page 1.

Melexis NV| Rozendaalstraat 12 | 8900 Ieper | Phone: +32 57 226 131 |

Register Legal Persons Ghent, division of Ieper 0435.604.729| V.A.T. BE0435.604.729

Disclaimer

Melexis NV published this content on 06 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 April 2022 07:58:04 UTC.


© Publicnow 2022
All news about MELEXIS N.V.
07/27Melexis NV Announces Interim Dividend, Payable on October 18, 2022
CI
07/27TRANSCRIPT : Melexis NV, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27Melexis NV Reports Earnings Results for the Second Quarter and Six Months Ended June 30..
CI
07/27Melexis Q2 2022 results – Second quarter sales of 208.4 million EUR
GL
07/27Melexis Q2 2022 results – Second quarter sales of 208.4 million EUR
AQ
07/27MELEXIS N.V. : Press Release
CO
07/27MELEXIS N.V. : Half-year results
CO
05/11MELEXIS N.V. : Ex-dividend day for final dividend
FA
05/10MELEXIS N.V. : Dividends
CO
05/10MELEXIS N.V. : Proxy Statments
CO
More news
Analyst Recommendations on MELEXIS N.V.
More recommendations
Financials
Sales 2022 832 M 845 M 845 M
Net income 2022 192 M 195 M 195 M
Net cash 2022 60,2 M 61,1 M 61,1 M
P/E ratio 2022 17,5x
Yield 2022 3,88%
Capitalization 3 321 M 3 394 M 3 373 M
EV / Sales 2022 3,92x
EV / Sales 2023 3,66x
Nbr of Employees 1 500
Free-Float 50,0%
Chart MELEXIS N.V.
Duration : Period :
Melexis N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MELEXIS N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 82,80 €
Average target price 84,88 €
Spread / Average Target 2,51%
EPS Revisions
Managers and Directors
Marc Biron Chief Executive Officer & Director
Karen van Griensven Chief Financial Officer
Françoise Chombar Chairman
Veerle Lozie Vice President-Operations & Information Technology
Damien Macq Chief Operating & Investment Officer
Sector and Competitors
1st jan.Capi. (M$)
MELEXIS N.V.-20.99%3 397
NVIDIA CORPORATION-35.44%475 487
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED-16.10%445 631
BROADCOM INC.-17.13%222 681
QUALCOMM, INC.-17.86%168 686
TEXAS INSTRUMENTS-2.21%168 396